{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:13:30Z","timestamp":1791231210005,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023MH173"],"award-info":[{"award-number":["ZR2023MH173"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2020QH26"],"award-info":[{"award-number":["ZR2020QH26"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024LSW010"],"award-info":[{"award-number":["ZR2024LSW010"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302149"],"award-info":[{"award-number":["82302149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M711987"],"award-info":[{"award-number":["2022M711987"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nbd.2025.107076","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:21:30Z","timestamp":1756509690000},"page":"107076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease"],"prefix":"10.1016","volume":"215","author":[{"given":"Tong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aocai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanfang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107076_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116443","article-title":"Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson\u2019s disease","volume":"406","author":"Azuma","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2025.107076_bb0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","volume":"16","author":"Boxer","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107076_bb0015","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107076_bb0020","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/ana.410320716","article-title":"Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia","volume":"32","author":"Dexter","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.107076_bb0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","article-title":"Progressive supranuclear palsy: pathology and genetics","volume":"17","author":"Dickson","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2025.107076_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29062","article-title":"Dynamics of nigral iron accumulation in Parkinson\u2019s disease: from diagnosis to late stage","author":"Du","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0035","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107076_bb0040","article-title":"Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson\u2019s disease","volume":"16","author":"Fedorow","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2025.107076_bb0045","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0050","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0055","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/jmri.25434","article-title":"Influence of regional iron on the motor impairments of Parkinson\u2019s disease: a quantitative susceptibility mapping study","volume":"45","author":"Guan","year":"2017","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nbd.2025.107076_bb0060","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11682-018-9842-z","article-title":"Quantitative susceptibility mapping as a biomarker for evaluating white matter alterations in Parkinson\u2019s disease","volume":"13","author":"Guan","year":"2019","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.nbd.2025.107076_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroimage.2018.06.007","article-title":"The influence of brain iron and myelin on magnetic susceptibility and effective transverse relaxation - a biochemical and histological validation study","volume":"179","author":"Hametner","year":"2018","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2025.107076_bb0070","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1002\/hbm.22928","article-title":"Region-specific disturbed iron distribution in early idiopathic Parkinson\u2019s disease measured by quantitative susceptibility mapping: magnetic susceptibility analysis in early PD","volume":"36","author":"He","year":"2015","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nbd.2025.107076_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.117810","article-title":"Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson\u2019s disease","volume":"230","author":"He","year":"2021","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2025.107076_bb0080","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria: MDS clinical diagnostic criteria for PSP","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2025.107076_bb0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000121388","article-title":"Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy","volume":"5","author":"Jellinger","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2025.107076_bb0095","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/hbm.25770","article-title":"Automatic detection of neuromelanin and iron in the midbrain nuclei using a magnetic resonance imaging -based brain template","volume":"43","author":"Jin","year":"2022","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nbd.2025.107076_bb0100","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/mds.10488","article-title":"Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank","volume":"18","author":"Josephs","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0105","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2169\/internalmedicine.50.5101","article-title":"Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD","volume":"50","author":"Kashihara","year":"2011","journal-title":"Intern. Med."},{"key":"10.1016\/j.nbd.2025.107076_bb0110","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00401-021-02289-0","article-title":"Latent trait modeling of tau neuropathology in progressive supranuclear palsy","volume":"141","author":"Kouri","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.107076_bb0115","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.neuroimage.2012.05.049","article-title":"Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study","volume":"62","author":"Langkammer","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2025.107076_bb0120","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.neuroimage.2010.11.088","article-title":"Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition","volume":"55","author":"Li","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2025.107076_bb0125","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/hbm.22360","article-title":"Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan: brain magnetic susceptibility over lifespan","volume":"35","author":"Li","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nbd.2025.107076_bb0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuroimage.2014.12.043","article-title":"A method for estimating and removing streaking artifacts in quantitative susceptibility mapping","volume":"108","author":"Li","year":"2015","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2025.107076_bb0135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jon.12957","article-title":"Quantitative evaluation of brain iron accumulation in different stages of Parkinson\u2019s disease","volume":"32","author":"Li","year":"2022","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.nbd.2025.107076_bb0140","first-page":"1429","article-title":"The value of quantitative susceptibility mapping and morphometry in the differential diagnosis of parkinsonism","volume":"46","author":"Li","year":"2025","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2025.107076_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ane.12546","article-title":"Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants","volume":"134","author":"Lopez","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2025.107076_bb0150","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1212\/WNL.0b013e318292a2d2","article-title":"The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy","volume":"80","author":"Massey","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107076_bb0155","article-title":"Quantitative susceptibility mapping in atypical Parkinsonisms","volume":"24","author":"Mazzucchi","year":"2019","journal-title":"NeuroImage: Clinical"},{"key":"10.1016\/j.nbd.2025.107076_bb0160","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3174\/ajnr.A4260","article-title":"Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease","volume":"36","author":"Murakami","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2025.107076_bb0165","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s00330-016-4622-x","article-title":"Magnetic resonance parkinsonism index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy","volume":"27","author":"Nigro","year":"2017","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.nbd.2025.107076_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2017.05.002","article-title":"Magnetic resonance parkinsonism index and midbrain to pons ratio: which index better distinguishes progressive supranuclear palsy patients with a low degree of diagnostic certainty from patients with Parkinson disease?","volume":"41","author":"Nigro","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0175","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.parkreldis.2014.04.005","article-title":"Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging","volume":"20","author":"Ohtsuka","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0180","series-title":"Ferritin Is Associated with the Aberrant Tau Filaments Present in Progressive Supranuclear Palsy","first-page":"9","volume":"152","author":"Perez","year":"1998"},{"key":"10.1016\/j.nbd.2025.107076_bb0185","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease: MDS-PD clinical diagnostic criteria","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0190","article-title":"Multimodal magnetic resonance imaging quantification of brain changes in progressive supranuclear palsy","volume":"10","author":"Pyatigorskaya","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0195","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.wnr.0000227984.84927.a7","article-title":"Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson\u2019s disease","volume":"17","author":"Sasaki","year":"2006","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2025.107076_bb0200","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/mds.29613","article-title":"Magnetic susceptibility in progressive supranuclear palsy variants, Parkinson\u2019s disease, and corticobasal syndrome","volume":"38","author":"Satoh","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0205","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1148\/radiol.2016160662","article-title":"In vivo assessment of brainstem depigmentation in Parkinson disease: potential as a severity marker for multicenter studies","volume":"283","author":"Schwarz","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.nbd.2025.107076_bb0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/archneur.63.8.1154","article-title":"Topography of dopamine transporter availability in progressive supranuclear palsy","volume":"63","author":"Seppi","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2025.107076_bb0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.parkreldis.2017.08.029","article-title":"Quantitative susceptibility mapping differentiates between parkinsonian disorders","volume":"44","author":"Sj\u00f6str\u00f6m","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0220","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/mds.23336","article-title":"Clinical correlates of similar pathologies in parkinsonian syndromes: parkinsonian clinicopathological correlations","volume":"26","author":"Song","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0225","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/mds.27365","article-title":"Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson\u2019s disease: neuromelanin-MRI and midbrain volumetry","volume":"33","author":"Taniguchi","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107076_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mrm.23000","article-title":"Whole brain susceptibility mapping using compressed sensing","volume":"67","author":"Wu","year":"2012","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.nbd.2025.107076_bb0235","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability","volume":"31","author":"Yushkevich","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2025.107076_bb0240","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroimage.2013.04.022","article-title":"Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging","volume":"78","author":"Zheng","year":"2013","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2025.107076_bb0245","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog. Neurobiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:21:59Z","timestamp":1772878919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125002931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":49,"alternative-id":["S0969996125002931"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107076","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107076"}}